Cargando…

Methylphenidate off-label use and safety

INTRODUCTION: Methylphenidate is a piperidine derivative structurally and pharmacologically similar to amphetamine. Methylphenidate is indicated for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 years of age and over when remedial measures alone prove insufficient. In adults, it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trenque, Thierry, Herlem, Emmanuelle, Abou Taam, Malak, Drame, Moustapha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Case Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162523/ https://www.ncbi.nlm.nih.gov/pubmed/25279275 http://dx.doi.org/10.1186/2193-1801-3-286

Ejemplares similares

Incidence, associated factors, and effect on renal function of amoxicillin crystalluria in patients receiving high doses of intravenous amoxicillin (The CRISTAMOX Study): A cohort study
por: Demotier, Sophie, et al.
Publicado: (2022)

The cardiovascular safety of methylphenidate
por: Jackson, John W
Publicado: (2016)

Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate
por: Kluge, Michael, et al.
Publicado: (2013)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Hypoglycemia associated with off-label sitagliptin use
por: Whitley, Heather P, et al.
Publicado: (2008)

Alopecia Associated with Use of Methylphenidate: A Case Series
por: Gnanavel, Sundar, et al.
Publicado: (2018)

Safety Consequences of Off-Label Drugs Used for COVID-19
por: Dasgupta, Nabarun
Publicado: (2021)

Cardiac adverse reactions with off-label Covid-19 treatments
Publicado: (2020)

PRIMARY HYPERSOMNIA : RESPONSE TO FLUOXETINE AND METHYLPHENIDATE
por: Andrade, Chittaranjan
Publicado: (1999)

Methylphenidate Induced Lip and Tongue Biting
por: Gokcen, Cem, et al.
Publicado: (2018)

Methylphenidate-Induced Menorrhagia in Twin Girls
por: Özdağ, Veysel, et al.
Publicado: (2022)

Antineoplastics: Pancytopenia and off-label use: case report
Publicado: (2020)

Nafamostat: Off-label use and hyperkalaemia: case report
Publicado: (2020)

Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021)

Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A Multi-center, Open-label Study in Korea
por: Kim, Bung-Nyun, et al.
Publicado: (2011)

Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
por: Lenk, Christian, et al.
Publicado: (2009)

The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects
por: Markowitz, John S., et al.
Publicado: (2022)

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023)

Multiple drugs: Lack off efficacy following off-label use: 2 case reports
Publicado: (2022)

Safety and Efficacy of Off-label and Unlicensed Medicines in Children
por: Lee, Ji-Hyun, et al.
Publicado: (2018)

Methylphenidate and suicidal ideation: Report of two cases
por: Arun, Priti, et al.
Publicado: (2014)

Actigraphic Recording of Manic Symptoms Induced by Methylphenidate
por: Lahti, Tuuli, et al.
Publicado: (2009)

Elasomeran/methylphenidate: Myocarditis: 2 case reports
Publicado: (2022)

Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension
por: Weiss, Margaret D., et al.
Publicado: (2020)

Case Report: Testicular failure possibly associated with chronic use of methylphenidate
por: Ramasamy, Ranjith, et al.
Publicado: (2014)

Manic Symptoms Due to Methylphenidate Use in an Adolescent with Traumatic Brain Injury
por: Ekinci, Ozalp, et al.
Publicado: (2016)

Use of Methylphenidate in Coexisting Major Depression, Loss of Libido and Erectile Dysfunction
por: Nazlı, Şerif Bora, et al.
Publicado: (2021)

Tocilizumab: Candidaemia and Off-label-use: 3 case reports
Publicado: (2020)

Hydroxychloroquine: Rash following off label use: case report
Publicado: (2020)

Chloroquine: Off-label use, haemolysis and methaemoglobinaemia: case report
Publicado: (2020)

Multiple drugs: Lymphocytopenia and off-label use: case report
Publicado: (2020)

Multiple drugs: Bradycardia and off-label use: case report
Publicado: (2021)

Hydroxychloroquine: Haemolysis following off-label use: case report
Publicado: (2021)

Tocilizumab: Acute hypertriglyceridaemia and off-label use: case report
Publicado: (2020)

Sarilumab: Thrombocytopenia during an off-label use: case report
Publicado: (2020)

Methylprednisolone: Bacteraemia following off label use: case report
Publicado: (2021)

Multiple drugs: No response and off label use: case report
Publicado: (2021)

Ceftriaxone: Cholelithiasis following off-label use: case report
Publicado: (2021)

Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)

Hydroxychloroquine: Eosinophilia following off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jn2kscnuq3cuob2o8ftc47tb5s